Accession Number: | 0000899243-20-001383 |
Date: | 2020-01-15 |
Issuer: | GW PHARMACEUTICALS PLC (GWPH) |
Original Submission Date: |
GUY GEOFFREY W DR
SOVEREIGN HOUSE, VISION PARK, HISTON
CAMBRIDGE, X0 CB24 9BZ
Title of Security | Transaction Date | 2a. Deemed Execution Date | Transaction Code | Shares | Acquired or Disposed | Price per share | 5. Amount of Securities Beneficially Owned Following Reported Transaction | 6. Ownership Form Direct or Indirect | Nature of Indirect Ownership |
---|---|---|---|---|---|---|---|---|---|
ORDINARY SHARES | 2020-01-15 | S | 300,000 | d | $9.47 | 7,421,521 | direct | ||
ORDINARY SHARES | 2020-01-15 | S | 600,000 | d | $9.42 | 6,821,521 | direct |
Title of Derivative Security | Conversion or Exercise Price of Derivative Security | Transaction Date | Deemed Execution Date | Transaction Code | Number of Derivative Securities Acquired (A) or Disposed of (D) | Date Exercisable | Expiration Date | Title and Amount of Securities Underlying Derivative Security | Price of Derivative Security | Number of derivative Securities Beneficially Owned Following Reported Transaction(s) | Ownership Form: Direct (D) or Indirect (I) | Nature of Indirect Beneficial Ownership |
---|
ID | footnote |
---|---|
f1 | the sales reported were effected pursuant to a rule 10b5-1 trading plan adopted by the reporting person on december 9, 2019. |
f2 | represented by american depositary shares of the issuer ("adss"). each ads represents twelve ordinary shares of the issuer. |
f3 | the price reported in column 4 is a price per ordinary share converted from price per ads. |